{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:36:37Z","timestamp":1790516197191,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10787-019-00575-8","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T10:19:39Z","timestamp":1550225979000},"page":"997-1010","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Regulatory effects of paeoniflorin-6\u2032-O-benzene sulfonate (CP-25) on dendritic cells maturation and activation via PGE2-EP4 signaling in adjuvant-induced arthritic rats"],"prefix":"10.1007","volume":"27","author":[{"given":"Xiao-yi","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-xun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"575_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1538\/expanim.57.45","volume":"57","author":"N Aghdami","year":"2008","unstructured":"Aghdami N, Gharibdoost F, Moazzeni SM (2008) Experimental autoimmune encephalomyelitis (EAE) induced by antigen pulsed dendritic cells in the C57BL\/6 mouse: Influence of injection route. Exp Anim 57:45\u201355","journal-title":"Exp Anim"},{"key":"575_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4110\/in.2016.16.1.44","volume":"16","author":"MS Ahmed","year":"2016","unstructured":"Ahmed MS, Bae YS (2016) Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside. Immune Netw 16:44\u201351","journal-title":"Immune Netw"},{"key":"575_CR3","first-page":"255","volume":"41","author":"A Balanescu","year":"2003","unstructured":"Balanescu A, Nat R, Regalia T, Radu E, Bojinca V, Ionescu R, Predescu V, Popescu E, Prede\u0163eanu D (2003) Correlation between the immunophenotypical presentation of dendritic cells and the clinical response to anti-rheumatic treatment in rheumatoid arthritis. Rom J Intern Med 41:255\u2013267","journal-title":"Rom J Intern Med"},{"key":"575_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245\u2013252","journal-title":"Nature"},{"key":"575_CR5","doi-asserted-by":"publisher","first-page":"26239","DOI":"10.1038\/srep26239","volume":"6","author":"Y Chang","year":"2016","unstructured":"Chang Y, Jia X, Wei F, Wang C, Sun X, Xu S, Yang X, Zhao Y, Chen J, Wu H, Zhang L, Wei W (2016) CP-25, a novel compound, protects against autoimmune arthritis by modulating immune mediators of inflammation and bone damage. Sci Rep 6:26239","journal-title":"Sci Rep"},{"key":"575_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3389\/fphar.2018.00563","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Wang Y, Wu H, Yan S, Chang Y, Wei W (2018) A modified compound from paeoniflorin, CP-25, suppressed immune responses and synovium inflammation in collagen-induced arthritis mice. Front Pharmacol 9:563","journal-title":"Front Pharmacol"},{"key":"575_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Natur 423:356\u2013361","journal-title":"Natur"},{"key":"575_CR8","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/eji.200738107","volume":"38","author":"F Flores-Borja","year":"2008","unstructured":"Flores-Borja F, Mauri C, Ehrenstein MR (2008) Restoring the balance: harnessing regulatory T cells for therapy in rheumatoid arthritis. Eur J Immunol 38:934\u2013937","journal-title":"Eur J Immunol"},{"key":"575_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00418-002-0384-4","volume":"117","author":"O Grauer","year":"2002","unstructured":"Grauer O, Wohlleben G, Seubert S, Weishaupt A, K\u00e4mpgen E, Gold R (2002) Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique. Histochem Cell Biol 117:351\u2013362","journal-title":"Histochem Cell Biol"},{"key":"575_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri1256","volume":"4","author":"H Hackstein","year":"2004","unstructured":"Hackstein H, Thomson AW (2004) Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4:24\u201334","journal-title":"Nat Rev Immunol"},{"key":"575_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1189\/jlb.1002483","volume":"73","author":"H Harizi","year":"2003","unstructured":"Harizi H, Grosset C, Gualde N (2003) Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes. J Leukoc Biol 73:756\u2013763","journal-title":"J Leukoc Biol"},{"key":"575_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/s10165-009-0240-7","volume":"20","author":"S Hayashi","year":"2010","unstructured":"Hayashi S, Miura Y, Tateishi K, Takahashi M, Kurosaka M (2010) Decoy receptor 3 is highly expressed in patients with rheumatoid arthritis. Mod Rheumatol 20:63\u201368","journal-title":"Mod Rheumatol"},{"key":"575_CR13","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.4049\/jimmunol.177.3.1567","volume":"177","author":"SF Helden Van","year":"2006","unstructured":"Van Helden SF, Krooshoop DJ, Broers KC, Raymakers RA, Figdor CG, van Leeuwen FN (2006) A critical role for prostaglandin E2 in podosome dissolution and induction of highspeed migration during dendritic cell maturation. J Immunol 177:1567\u20131574","journal-title":"J Immunol"},{"key":"575_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1084\/jem.20051310","volume":"203","author":"T Honda","year":"2006","unstructured":"Honda T, Segi-Nishida E, Miyachi Y, Narumiya S (2006) Prostacyclin-IP signaling and prostaglandin E2-EP2\/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med 203:325\u2013335","journal-title":"J Exp Med"},{"key":"575_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.intimp.2014.08.024","volume":"23","author":"XY Jia","year":"2014","unstructured":"Jia XY, Chang Y, Sun XJ, Dai X, Wei W (2014) The role of prostaglandin E2 receptor signaling of dendritic cells in rheumatoid arthritis. Int Immunopharmacol 23:163\u2013169","journal-title":"Int Immunopharmacol"},{"key":"575_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jep.2016.05.034","volume":"189","author":"X Jia","year":"2016","unstructured":"Jia X, Wei F, Sun X, Chang Y, Xu S, Yang X, Wang C, Wei W (2016) CP-25 attenuates the inflammatory response of fibroblast-like synoviocytes co-cultured with BAFF-activated CD4(+) T cells. J Ethnopharmacol 189:194\u2013201","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"575_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/s41401-018-0196-2","volume":"40","author":"Xiao-yi Jia","year":"2019","unstructured":"Jia XY, Chang Y, Wei F, Dai X, Wu YJ, Sun XJ, Xu S, Wu HX, Wang C, Yang XZ, Wei W (2019) CP-25 reverses prostaglandin E4 receptor desensitization-induced fibroblast-like synoviocyte dysfunction via the G protein-coupled receptor kinase 2 in autoimmune arthritis. Acta Pharmacol Sin. \n                    https:\/\/doi.org\/10.1038\/s41401-018-0196-2","journal-title":"Acta Pharmacologica Sinica"},{"key":"575_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1124\/jpet.106.111146","volume":"320","author":"GL Jiang","year":"2007","unstructured":"Jiang GL, Nieves A, Im WB, Old DW, Dinh DT, Wheeler L (2007) The prevention of colitis by E Prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration. Pharmaol Exp Ther 320:22\u201328","journal-title":"Pharmaol Exp Ther"},{"key":"575_CR19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.4049\/jimmunol.181.1.721","volume":"181","author":"T Khayrullina","year":"2008","unstructured":"Khayrullina T, Yen JH, Jing H, Ganea D (2008) In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12\/IL-23 balance and promotes differentiation of Th17 cells. J Immunol 181:721\u2013735","journal-title":"J Immunol"},{"key":"575_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","volume":"373","author":"L Klareskog","year":"2009","unstructured":"Klareskog L, Catrina A, Paget S (2009) Rheumatoid arthritis. Lancet 373:659\u2013672","journal-title":"Lancet"},{"key":"575_CR22","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2353\/ajpath.2008.070703","volume":"172","author":"MC Lebre","year":"2008","unstructured":"Lebre MC, Jongbloed SL, Tas SW, Smeets TJ, McInnes IB, Tak PP (2008) Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles. Am J Pathol 172:940\u2013950","journal-title":"Am J Pathol"},{"key":"575_CR23","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s11596-010-0650-y","volume":"30","author":"Y Liu","year":"2010","unstructured":"Liu Y, Wang S, Shen L, Xu Y (2010) Effects of simvastatin on the function of dendritic cells in patients with rheumatic arthritis. J Huazhong Univ Sci Technol Med Sci 30:741\u2013745","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"575_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0049-0172(03)00134-3","volume":"33","author":"J Martel-Pelletier","year":"2003","unstructured":"Martel-Pelletier J, Pelletier JP, Fahmi H (2003) Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 33:155\u2013167","journal-title":"Semin Arthritis Rheum"},{"key":"575_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1172\/JCI0215528","volume":"110","author":"JM McCoy","year":"2002","unstructured":"McCoy JM, Wicks JR, Audoly LP (2002) The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 110:651\u2013658","journal-title":"J Clin Invest"},{"key":"575_CR26","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1084\/jem.186.9.1603","volume":"186","author":"C Rieser","year":"1997","unstructured":"Rieser C, B\u00f6ck G, Klocker H, Bartsch G, Thurnher M (1997) Prostaglandin E2 and tumor necrosis factor a cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med 186:1603\u20131608","journal-title":"J Exp Med"},{"key":"575_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1084\/jem.182.2.389","volume":"182","author":"F Sallusto","year":"1995","unstructured":"Sallusto F, Cella M, Danieli C, Lanzavecchia A (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182:389\u2013400","journal-title":"J Exp Med"},{"key":"575_CR28","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.4049\/jimmunol.167.3.1758","volume":"167","author":"F Santiago-Schwarz","year":"2001","unstructured":"Santiago-Schwarz F, Anand P, Liu S, Carsons SE (2001) Dendritic cells (DCs) in rheumatoid arthritis (RA): progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate Th1 inflammatory-type responses. J Immunol 167:1758\u20131768","journal-title":"J Immunol"},{"key":"575_CR29","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2741\/1560","volume":"10","author":"S Sarkar","year":"2005","unstructured":"Sarkar S, Fox DA (2005) Dendritic cells in rheumatoid arthritis. Front Biosci 10:656\u2013665","journal-title":"Front Biosci"},{"key":"575_CR30","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1182\/blood-2010-01-263509","volume":"16","author":"C Schirmer","year":"2010","unstructured":"Schirmer C, Klein C, von Bergen M, Simon JC, Saalbach A (2010) Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells. Blood 16:1715\u20131725","journal-title":"Blood"},{"key":"575_CR31","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376:1094\u20131108","journal-title":"Lancet"},{"key":"575_CR32","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1096\/fj.03-1367fje","volume":"18","author":"AF Sheibanie","year":"2004","unstructured":"Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D (2004) Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J 18:1318\u20131320","journal-title":"FASEB J"},{"key":"575_CR33","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1182\/blood-2011-03-342428","volume":"119","author":"P Singh","year":"2012","unstructured":"Singh P, Hoggatt J, Hu P, Speth JM, Fukuda S, Breyer RM, Pelus LM (2012) Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells. Blood 119:1671\u20131682","journal-title":"Blood"},{"key":"575_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.berh.2014.10.023","volume":"28","author":"JF Swart","year":"2014","unstructured":"Swart JF, Wulffraat NM (2014) Mesenchymal stromal cells for treatment of arthritis. Best Pract Res Clin Rheumatol 28:589\u2013603","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"575_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/jlb.66.2.286","volume":"66","author":"R Thomas","year":"1999","unstructured":"Thomas R, MacDonald KP, Pettit AR, Cavanagh LL, Padmanabha J, Zehntner S (1999) Dendritic cells and the pathogenesis of rheumatoid arthritis. J Leukoc Biol 66:286\u2013292","journal-title":"J Leukoc Biol"},{"key":"575_CR36","doi-asserted-by":"publisher","first-page":"9044","DOI":"10.1073\/pnas.1332766100","volume":"100","author":"CE Trebino","year":"2003","unstructured":"Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, Umland JP, Pandher K, Lapointe JM, Saha S, Roach ML, Carter D, Thomas NA, Durtschi BA, McNeish JD, Hambor JE, Jakobsson PJ, Carty TJ, Perez JR, Audoly LP (2003) Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA 100:9044\u20139049","journal-title":"Proc Natl Acad Sci USA"},{"key":"575_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0008-8749(03)00158-8","volume":"223","author":"E Vassiliou","year":"2003","unstructured":"Vassiliou E, Jing H, Ganea D (2003) Prostaglandin E2 inhibits TNF-\u03b1 production in murine bone marrow-derived dendritic cells. Cell Immunol 223:120\u2013132","journal-title":"Cell Immunol"},{"key":"575_CR38","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s10753-018-0757-z","volume":"41","author":"Y Wang","year":"2018","unstructured":"Wang Y, Han CC, Cui D, Luo TT, Li Y, Zhang Y, Ma Y, Wei W (2018) Immunomodulatory effects of CP-25 on splenic T cells of rats with adjuvant arthritis. Inflammation 41:1049\u20131063","journal-title":"Inflammation"},{"key":"575_CR39","doi-asserted-by":"publisher","first-page":"24548","DOI":"10.1038\/srep24548","volume":"6","author":"H Wu","year":"2016","unstructured":"Wu H, Chen J, Song S, Yuan P, Liu L, Zhang Y, Zhou A, Chang Y, Zhang L, Wei W (2016) \u03b22-adrenoceptor signaling reduction in dendritic cells is involved in the inflammatory response in adjuvant-induced arthritic rats. Sci Rep 6:24548","journal-title":"Sci Rep"},{"key":"575_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fphar.2018.00004","volume":"9","author":"YJ Wu","year":"2018","unstructured":"Wu YJ, Chen HS, Chen WS, Dong J, Dong XJ, Dai X, Huang Q, Wei W (2018) CP-25 Attenuates the Activation of CD4(+) T Cells Stimulated with Immunoglobulin D in Human. Front Pharmacol 9:4","journal-title":"Front Pharmacol"},{"key":"575_CR41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.0105-2896.2006.00422.x","volume":"212","author":"S Yamazaki","year":"2006","unstructured":"Yamazaki S, Inaba K, Tarbell KV, Steinman RM (2006) Dendritic cells expand antigen-specific Foxp3+CD25+CD4+ regulatory T cells including suppressors of alloreactivity. Immunol Rev 212:314\u2013329","journal-title":"Immunol Rev"},{"key":"575_CR42","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1172\/JCI16492","volume":"111","author":"L Yang","year":"2003","unstructured":"Yang L, Yamagata N, Yadav R, Brandon S, Courtney RL, Morrow JD, Shyr Y, Boothby M, Joyce S, Carbone DP, Breyer RM (2003) Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. J Clin Invest 111:727\u2013735","journal-title":"J Clin Invest"},{"key":"575_CR43","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.biopha.2018.12.040","volume":"110","author":"X Yang","year":"2019","unstructured":"Yang X, Zhao Y, Jia X, Wang C, Wu Y, Zhang L, Chang Y, Wei W (2019) CP-25 combined with MTX\/LEF ameliorates the progression of adjuvant-induced arthritis by the inhibition on GRK2 translocation. Biomed Pharmacother 110:834\u2013843","journal-title":"Biomed Pharmacother"},{"key":"575_CR45","doi-asserted-by":"publisher","first-page":"38913","DOI":"10.1074\/jbc.M111.252932","volume":"286","author":"JH Yen","year":"2011","unstructured":"Yen JH, Kocieda VP, Jing H, Ganea D (2011) Prostaglandin E2 induces matrix metalloproteinase 9 expression in dendritic cells through two independent signaling pathways leading to activator protein 1 (AP-1) activation. J Biol Chem 286:38913\u201338923","journal-title":"J Biol Chem"},{"key":"575_CR46","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3389\/fphar.2017.00933","volume":"8","author":"F Zhang","year":"2017","unstructured":"Zhang F, Shu JL, Li Y, Wu YJ, Zhang XZ, Han L, Tang XY, Wang C, Wang QT, Chen JY, Chang Y, Wu HX, Zhang LL, Wei W (2017) CP-25, a novel anti-inflammatory and immunomodulatory drug, inhibits the functions of activated human B cells through regulating BAFF and TNF-alpha signaling and comparative efficacy with biological agents. Front Pharmacol 8:933","journal-title":"Front Pharmacol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-019-00575-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-019-00575-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-019-00575-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T19:06:15Z","timestamp":1581707175000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-019-00575-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["575"],"URL":"https:\/\/doi.org\/10.1007\/s10787-019-00575-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]},"assertion":[{"value":"24 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}